| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33c922e05f6133b7d72dbb849d77487d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-36 |
| filingDate |
1994-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88c568a91586663fc1c68ce9d32639b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a80d87e244226d518a2276dc041be541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfaa429dac33e020fadf2056d16477a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_968b6c8d60080b6d2fc713e24074eb01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3934f13017e034135a2bcc4a5a3b50b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1cd3e63d48780f9b557e008e096074d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571066725b97b6adbf600e41c3b5d0fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8de1fe86a1c20e3fac57361f4f805cab |
| publicationDate |
1998-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-0138603-B1 |
| titleOfInvention |
Human immunodeficiency virus (HIV) protease inhibitory compound, preparation method thereof, and composition comprising the same (HUMAN HIV PROTEASE INHIBITOR, PROCESS FOR THE PREPARATION THEREOF AND COMPOSITION CONTAINING SAME) |
| abstract |
The present invention provides a novel compound that inhibits human immunodeficiency virus (HIV) protease represented by the following general formula (I) and a method for preparing the same, and the treatment of acquired immunodeficiency syndrome caused by HIV infection containing the compound as an active ingredient. Or to a composition for prevention.n n n n n n n n Wheren n n A, D and R 1 are as defined in the specification. |
| priorityDate |
1994-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |